These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers. Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092 [TBL] [Abstract][Full Text] [Related]
4. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer. Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396 [TBL] [Abstract][Full Text] [Related]
5. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong. Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053 [TBL] [Abstract][Full Text] [Related]
6. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients. Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510 [TBL] [Abstract][Full Text] [Related]
7. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC; Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study. Lindegaard JC; Petric P; Schmid MP; Nesvacil N; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Kirchheiner K; Spampinato S; Jürgenliemk-Schulz I; Tanderup K; Kirisits C; Pötter R Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):379-389. PubMed ID: 35157992 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE). Yoshida K; Jastaniyah N; Sturdza A; Lindegaard J; Segedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz I; Haie-Meder C; Sasaki R; Pötter R Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):788-96. PubMed ID: 26530747 [TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study. Schmid MP; Lindegaard JC; Mahantshetty U; Tanderup K; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza A; Hoskin P; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Petric P; Ramazanova D; Ristl R; Kannan S; Hawaldar R; Ecker S; Kirchheiner K; Tan LT; Nout R; Nesvacil N; de Leeuw A; Pötter R; Kirisits C; J Clin Oncol; 2023 Apr; 41(10):1933-1942. PubMed ID: 36599120 [TBL] [Abstract][Full Text] [Related]
11. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition? Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168 [TBL] [Abstract][Full Text] [Related]
12. Value of Magnetic Resonance Imaging Without or With Applicator in Place for Target Definition in Cervix Cancer Brachytherapy. Pötter R; Federico M; Sturdza A; Fotina I; Hegazy N; Schmid M; Kirisits C; Nesvacil N Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):588-97. PubMed ID: 26867887 [TBL] [Abstract][Full Text] [Related]
13. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study. Ke T; Wang J; Zhang N; Zhao H; Guo X; Zhao Z; Mao Z; Cheng G Strahlenther Onkol; 2023 Feb; 199(2):131-140. PubMed ID: 36109399 [TBL] [Abstract][Full Text] [Related]
14. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome. Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516 [TBL] [Abstract][Full Text] [Related]
16. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results. Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174 [TBL] [Abstract][Full Text] [Related]
17. Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of Cervical Cancer and its Impact on Clinical Outcome. Singhal S; Veeratterapillay J; Locks S; Morgan D; Patil R; Chamberlain HM Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):442-451. PubMed ID: 35123850 [TBL] [Abstract][Full Text] [Related]
18. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective. Lindegaard JC; Fokdal LU; Nielsen SK; Juul-Christensen J; Tanderup K Acta Oncol; 2013 Oct; 52(7):1510-9. PubMed ID: 23962242 [TBL] [Abstract][Full Text] [Related]
19. Impact of treatment time and dose escalation on local control in locally advanced cervical cancer treated by chemoradiation and image-guided pulsed-dose rate adaptive brachytherapy. Mazeron R; Castelnau-Marchand P; Dumas I; del Campo ER; Kom LK; Martinetti F; Farha G; Tailleur A; Morice P; Chargari C; Lefkopoulos D; Haie-Meder C Radiother Oncol; 2015 Feb; 114(2):257-63. PubMed ID: 25497872 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer. Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]